A Massachusetts biotechnology company has cracked the code on cannabis, and will roll out the first-ever sequencing of the entire pot genome today. the potentially huge medicinal herb industry could use this data to offer cancer patients and others in constant pain new, better kinds of curative cannabis scientifically designed to target their specific conditions.